About PhotoThera
PhotoThera is a company based in Carlsbad (United States) founded in 1997. It operates as a B2B. PhotoThera has raised $80.5 million across 2 funding rounds from investors including Warburg Pincus, Solstice Capital and The Vertical Group. PhotoThera operates in a competitive market with competitors including Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others.
- Headquarter Carlsbad, United States
- SectorsHealthcare
- Website photothera.com
- Total Equity Funding$80.5M (USD)
in 2 rounds
- Latest Funding Round$50M (USD), Series D
May 2009
- InvestorsWarburg Pincus
& 5 more
Funding Insights of PhotoThera
PhotoThera has successfully raised a total of $80.5M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $80.5M
- Total Rounds 2
- Last Round Series D — $50M
- First Round $30.5M
(Apr 2006)
- Investors Count 6
All 2 funding rounds of PhotoThera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2009 | $50M | Series D | – | Warburg Pincus, The Vertical Group | – |
| Apr 2006 | $30.5M | Series C | – | Delphi Ventures, De Novo Ventures | – |
6 investors in total: 6 institutional.
Investors in PhotoThera
PhotoThera has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Warburg Pincus, Solstice Capital and The Vertical Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Investments in early and late-stage US companies are made. | – | vertical-group.com | Basking Ridge, United States | |
- | – | hamiltonbioventures.com | - | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
- | – | denovovc.com | - | |
US focused seed & early stage Micro VC firm | 1995 | solcap.com | Salem, United States |
Investor details for PhotoThera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PhotoThera
3 dated milestones of PhotoThera across 12 years, from founding to its latest funding, stage changes and deals.
- Founded PhotoThera is founded.
- Funding First funding round of $30.5M.
- Funding Latest funding round, Series D, of $50.0M.
Competitors of PhotoThera
PhotoThera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avation.com | 1999 | Columbus, United States | $34.92M | – | Wearable tibial nerve stimulation device treats overactive bladder symptoms. | |
| tulavi.com | 2020 | Mountain View, United States | $4M | – | Therapeutic devices for neurally mediated diseases are developed. | |
| biocircuit.com | 2016 | Atlanta, United States | $13.65M | – | Non-invasive electrophysiology devices are developed to monitor peripheral nerves. | |
| rxfunction.com | 2010 | Minneapolis, United States | $39.95M | 30 | Wearable prostheses for sensory peripheral neuropathy patients are developed. | |
| epineurontech.com | 2016 | Hamilton, Canada | – | – | Medical devices for peripheral nerve injury treatment are provided. | |
| monarchbioimplants.com | 2016 | Root, Switzerland | $24.93M | – | Developer of bioimplant for peripheral nerve repair | |
| micro-leads.com | 2014 | Boston, United States | – | – | Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed. | |
| renerva.com | 2017 | Pittsburgh, United States | $1.28M | – | Implants for peripheral nerve repair are developed for injury treatment. |
Detailed competitors of PhotoThera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to PhotoThera
10 companies that operate in the same segment as PhotoThera (Diversified Medical Devices), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | – | USD 36.36 B | 95,000 | |
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | – | USD 20.07 B | 53,000 | |
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | – | USD 94.18 B | 139,800 | |
Diagnostic and surgical products for women's healthcare are provided. | 1985 | Marlborough, Massachusetts, United States | – | USD 4.1 B | 7,060 | |
Developer of drug candidates for the treatment of rare CNS disorders | 1971 | Boston, Massachusetts, United States | USD 105.8 M | – | 487 | |
Surgical instruments are manufactured for multiple therapeutic areas. | 1987 | Utica, New York, United States | – | USD 1.37 B | 3,900 | |
A wide range of medical devices is developed by HOYA. | 1941 | Tokyo, Tokyo, Japan | – | USD 5.94 B | 37,910 | |
Medical devices for cardiac and neuromodulation therapies are manufactured globally. | 1976 | Saint Paul, Minnesota, United States | – | – | – | |
Complex healthcare challenges are addressed through technology solutions by Commure. | 2016 | San Francisco, California, United States | USD 823.3 M | – | 316 | |
Provider of medical devices for emergency medicine and various health conditions | 1943 | Wayne, United States | – | USD 1.99 B | 14,100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PhotoThera
PhotoThera was founded in 1997 and raised its 1st funding round 9 years after it was founded.
PhotoThera is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
PhotoThera is a funded company, having raised a total of $80.5M across 2 funding rounds to date. The company's 1st funding round was a Series C of $30.5M, raised on Apr 2006.
PhotoThera, established in 1997 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, laser therapy, and therapeutic devices. Provides advanced laser therapy solutions for healthcare applications. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
PhotoThera's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
PhotoThera has 6 investors. Key investors include Warburg Pincus, Solstice Capital, The Vertical Group, Hamilton BioVentures, and Delphi Ventures.